These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 11245398)
1. Effects of subchronic parathion exposure on cyclosporine pharmacokinetics in rats. Gelal A; Gumustekin M; Kalkan S; Guven H; Eminoglu O J Toxicol Environ Health A; 2001 Feb; 62(4):289-94. PubMed ID: 11245398 [TBL] [Abstract][Full Text] [Related]
2. Effects of neostigmine on the pharmacokinetics of intravenous parathion in rats. Hurh E; Lee EJ; Kim YG; Kim SY; Kim SH; Kim YC; Lee MG Res Commun Mol Pathol Pharmacol; 2000; 108(3-4):261-73. PubMed ID: 11913717 [TBL] [Abstract][Full Text] [Related]
3. In vivo interaction between chlorpyrifos and parathion in adult rats: sequence of administration can markedly influence toxic outcome. Karanth S; Olivier K; Liu J; Pope C Toxicol Appl Pharmacol; 2001 Dec; 177(3):247-55. PubMed ID: 11749124 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of oral cyclosporine (Neoral) in heart transplant recipients during the immediate period after surgery. Banner NR; David OJ; Leaver N; Davis J; Breen J; Johnston A; Yacoub MH Transpl Int; 2002 Dec; 15(12):649-54. PubMed ID: 12478413 [TBL] [Abstract][Full Text] [Related]
5. Toxicokinetics of parathion and paraoxon in rainbow trout after intravascular administration and water exposure. Abbas R; Schultz IR; Doddapaneni S; Hayton WL Toxicol Appl Pharmacol; 1996 Jan; 136(1):194-9. PubMed ID: 8560474 [TBL] [Abstract][Full Text] [Related]
6. [The effect of tetramethylpyrazine on the pharmacokinetics of intragastrically administered cyclosporine A in rats]. Liu XL; Tang J; Song J; He J; Xu P; Peng WX Yao Xue Xue Bao; 2006 Sep; 41(9):882-7. PubMed ID: 17111838 [TBL] [Abstract][Full Text] [Related]
7. Identification of a reversible component in the in vitro inhibition of rat hepatic cytochrome P450 2B1 by parathion. Murray M; Butler AM J Pharmacol Exp Ther; 1995 Feb; 272(2):639-44. PubMed ID: 7853177 [TBL] [Abstract][Full Text] [Related]
8. Effect of berberine on the pharmacokinetics of substrates of CYP3A and P-gp. Qiu W; Jiang XH; Liu CX; Ju Y; Jin JX Phytother Res; 2009 Nov; 23(11):1553-8. PubMed ID: 19370549 [TBL] [Abstract][Full Text] [Related]
9. Longitudinal assessment of everolimus in de novo renal transplant recipients over the first post-transplant year: pharmacokinetics, exposure-response relationships, and influence on cyclosporine. Kovarik JM; Kahan BD; Kaplan B; Lorber M; Winkler M; Rouilly M; Gerbeau C; Cambon N; Boger R; Rordorf C; Clin Pharmacol Ther; 2001 Jan; 69(1):48-56. PubMed ID: 11180038 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of cholinesterase enzymes following a single dermal dose of chlorpyrifos and methyl parathion, alone and in combination, in pregnant rats. Abu-Qare AW; Abdel-Rahman A; Brownie C; Kishk AM; Abou-Donia MB J Toxicol Environ Health A; 2001 Jun; 63(3):173-89. PubMed ID: 11405414 [TBL] [Abstract][Full Text] [Related]
11. Pomelo juice, but not cranberry juice, affects the pharmacokinetics of cyclosporine in humans. Grenier J; Fradette C; Morelli G; Merritt GJ; Vranderick M; Ducharme MP Clin Pharmacol Ther; 2006 Mar; 79(3):255-62. PubMed ID: 16513449 [TBL] [Abstract][Full Text] [Related]
12. Disposition and miotic effects of oral alfentanil: a potential noninvasive probe for first-pass cytochrome P4503A activity. Kharasch ED; Hoffer C; Walker A; Sheffels P Clin Pharmacol Ther; 2003 Mar; 73(3):199-208. PubMed ID: 12621385 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of the role of formulation on parathion toxicity. Puga FR; Rodrigues MA Ecotoxicol Environ Saf; 1996 Oct; 35(1):38-40. PubMed ID: 8930503 [TBL] [Abstract][Full Text] [Related]
14. Effect of atorvastatin on cyclosporine pharmacokinetics in liver transplant recipients. Taylor PJ; Kubler PA; Lynch SV; Allen J; Butler M; Pillans PI Ann Pharmacother; 2004 Feb; 38(2):205-8. PubMed ID: 14742751 [TBL] [Abstract][Full Text] [Related]
15. Effect of subacute methyl parathion administration on the pharmacokinetics and pharmacodynamics of nifedipine in rats. Gelal A; Eminoglu O; Kaplan YC; Kalkan S Environ Toxicol Pharmacol; 2007 Jul; 24(1):1-4. PubMed ID: 21783781 [TBL] [Abstract][Full Text] [Related]
16. Effect of in vivo nicotine exposure on chlorpyrifos pharmacokinetics and pharmacodynamics in rats. Lee S; Poet TS; Smith JN; Busby-Hjerpe AL; Timchalk C Chem Biol Interact; 2010 Mar; 184(3):449-57. PubMed ID: 20097188 [TBL] [Abstract][Full Text] [Related]
17. CYP3A5 and MDR1 genetic polymorphisms and cyclosporine pharmacokinetics after renal transplantation. Anglicheau D; Thervet E; Etienne I; Hurault De Ligny B; Le Meur Y; Touchard G; Büchler M; Laurent-Puig P; Tregouet D; Beaune P; Daly A; Legendre C; Marquet P Clin Pharmacol Ther; 2004 May; 75(5):422-33. PubMed ID: 15116055 [TBL] [Abstract][Full Text] [Related]
18. Effects of liver fibrosis on verapamil pharmacokinetics in rats. Chen M; Xu D; Hu XL; Wang H Clin Exp Pharmacol Physiol; 2008 Mar; 35(3):287-94. PubMed ID: 17973928 [TBL] [Abstract][Full Text] [Related]
19. Disposition of tacrolimus in isolated perfused rat liver: influence of troleandomycin, cyclosporine, and gg918. Wu CY; Benet LZ Drug Metab Dispos; 2003 Nov; 31(11):1292-5. PubMed ID: 14570757 [TBL] [Abstract][Full Text] [Related]
20. Oral paclitaxel and concurrent cyclosporin A: targeting clinically relevant systemic exposure to paclitaxel. Britten CD; Baker SD; Denis LJ; Johnson T; Drengler R; Siu LL; Duchin K; Kuhn J; Rowinsky EK Clin Cancer Res; 2000 Sep; 6(9):3459-68. PubMed ID: 10999729 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]